TherapeuticsMD, Inc. (TXMD)
NASDAQ: TXMD · Real-Time Price · USD
2.100
+0.030 (1.45%)
At close: Apr 28, 2026, 4:00 PM EDT
2.100
0.00 (0.00%)
After-hours: Apr 28, 2026, 6:13 PM EDT

Company Description

TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States.

It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names.

The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors.

TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.

TherapeuticsMD, Inc.
TherapeuticsMD logo
Country United States
Founded 2008
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 1
CEO Marlan Walker

Contact Details

Address:
951 Yamato Road, Suite 220
Boca Raton, Florida 33431
United States
Phone 561 961 1900
Website therapeuticsmd.com

Stock Details

Ticker Symbol TXMD
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000025743
CUSIP Number 88338N206
ISIN Number US88338N2062
Employer ID 87-0233535
SIC Code 2834

Key Executives

Name Position
Marlan D. Walker J.D. Chief Executive Officer
Joseph A. Ziegler Principal Financial and Accounting Officer

Latest SEC Filings

Date Type Title
Apr 6, 2026 SCHEDULE 13G Filing
Apr 1, 2026 10-K/A [Amend] Annual report
Apr 1, 2026 NT 10-K Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405
Mar 30, 2026 8-K Current Report
Mar 30, 2026 10-K Annual Report
Jan 21, 2026 8-K Current Report
Dec 16, 2025 8-K Current Report
Nov 13, 2025 8-K Current Report
Nov 12, 2025 10-Q Quarterly Report
Nov 3, 2025 ARS Filing